{"id":346,"date":"2026-09-05T10:19:29","date_gmt":"2026-09-05T10:19:29","guid":{"rendered":"http:\/\/ashadocs.org\/?psych_scale=panic-disorder-severity-scale-pdss-sr-2"},"modified":"2026-09-05T10:19:29","modified_gmt":"2026-09-05T10:19:29","slug":"panic-disorder-severity-scale-pdss-sr-2","status":"publish","type":"psych_scale","link":"https:\/\/ashadocs.org\/?psych_scale=panic-disorder-severity-scale-pdss-sr-2","title":{"rendered":"Panic Disorder Severity Scale (PDSS-SR)"},"content":{"rendered":"<h2>Abstract<\/h2>\n<p>The <strong>Panic Disorder Severity Scale \u2013 Self-Report (PDSS-SR)<\/strong> is a widely utilized, psychometrically validated 7-item instrument engineered to quantify the overall severity of <a href=\"https:\/\/en.wikipedia.org\/wiki\/Panic_disorder\" target=\"_blank\" rel=\"noopener noreferrer\">panic disorder<\/a>, with or without <a href=\"https:\/\/en.wikipedia.org\/wiki\/Agoraphobia\" target=\"_blank\" rel=\"noopener noreferrer\">agoraphobia<\/a>. Originally derived from the clinician-administered Panic Disorder Severity Scale (PDSS; Shear et al., 1997), the self-report version was developed by Houck and colleagues (2002) to provide a time- and cost-efficient assessment tool that preserves the psychometric rigor of the interview-based interview format. The PDSS-SR evaluates seven distinct clinical dimensions central to DSM-IV and DSM-5 diagnostic frameworks: panic attack frequency, distress experienced during attacks, anticipatory anxiety, situational\/agoraphobic avoidance, interoceptive avoidance, occupational\/work impairment, and social\/interpersonal impairment. Each item is scored on a 5-point ordinal metric ranging from 0 (indicating no impairment or absence of symptoms) to 4 (representing extreme, pervasive, or incapacitating severity), yielding an aggregate composite score from 0 to 28, or a dimensional mean score from 0 to 4. Across clinical trials, psychiatric outpatient samples, and cross-cultural cohorts, the PDSS-SR demonstrates exemplary internal consistency (<a href=\"https:\/\/en.wikipedia.org\/wiki\/Cronbach%27s_alpha\" target=\"_blank\" rel=\"noopener noreferrer\">Cronbach&#8217;s alpha<\/a> typically ranging between .91 and .94), robust test-retest reliability (<span class=\"arabpsy-math-inline\" data-latex=\"r = .71\u2013.88\">$r = .71\u2013.88$<\/span>), and elevated convergent validity with related constructs such as the Beck Anxiety Inventory (BAI), the Hamilton Anxiety Rating Scale (HAM-A), and the Mobility Inventory for Agoraphobia (MIA). Furthermore, confirmatory factor analyses support either a robust unidimensional construct or a correlated two-factor architecture capturing core panic symptoms and functional avoidance\/impairment. The PDSS-SR represents a cornerstone outcome measure in contemporary psychiatric epidemiology, clinical trials evaluating pharmacotherapies and cognitive-behavioral therapy (CBT), and routine ambulatory clinical tracking.<\/p>\n<h2>Keywords<\/h2>\n<p>Panic Disorder Severity Scale, PDSS-SR, Panic Disorder, Agoraphobia, Psychometrics, Anticipatory Anxiety, Interoceptive Avoidance, Factor Analysis, Measurement Invariance, Treatment Outcome<\/p>\n<h2>Authors<\/h2>\n<p>The Panic Disorder Severity Scale was initially conceptualized and operationalized as a clinician-administered semi-structured interview by a multi-institutional collaborative consortium of leading clinical researchers in the anxiety disorders domain (Shear et al., 1997). The self-report adaptation (PDSS-SR) was subsequently validated to mirror the clinician interview by Houck and colleagues (2002).<\/p>\n<ul>\n<li><strong>M. Katherine Shear, M.D.<\/strong> \u2013 Marion E. Kenworthy Professor of Psychiatry in Social Work at Columbia University School of Social Work and Columbia University College of Physicians and Surgeons; former director of the Panic, Anxiety, and Complicated Grief Programs at the University of Pittsburgh School of Medicine.<\/li>\n<li><strong>Timothy A. Brown, Psy.D.<\/strong> \u2013 Professor of Psychology and Research Director at the Center for Anxiety and Related Disorders (CARD), Boston University; international authority on structural equation modeling, psychometric evaluation, and the latent structure of emotional disorders.<\/li>\n<li><strong>David H. Barlow, Ph.D., ABPP<\/strong> \u2013 Professor Emeritus of Psychology and Psychiatry at Boston University, Founder and Director Emeritus of CARD, and pioneer in the theoretical conceptualization and cognitive-behavioral treatment of anxiety and panic pathology.<\/li>\n<li><strong>Roy Money, M.S.W.<\/strong> \u2013 Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut.<\/li>\n<li><strong>Dianne E. Sholomskas, Ph.D.<\/strong> \u2013 Department of Psychiatry, Yale University School of Medicine; specialist in anxiety disorders and protocol development.<\/li>\n<li><strong>Scott W. Woods, M.D.<\/strong> \u2013 Professor of Psychiatry, Yale University School of Medicine; director of clinical research in psychotic and anxiety spectrum conditions.<\/li>\n<li><strong>Jack M. Gorman, M.D.<\/strong> \u2013 Former Professor of Psychiatry at Mount Sinai School of Medicine and Columbia University; renowned neurobiologist and panic disorder trialist.<\/li>\n<li><strong>Larry A. Papp, M.D.<\/strong> \u2013 Department of Psychiatry, Columbia University College of Physicians and Surgeons and the New York State Psychiatric Institute.<\/li>\n<li><strong>Peter R. Houck, M.S.<\/strong> (Primary investigator for the self-report validation) \u2013 Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine.<\/li>\n<\/ul>\n<h2>Purpose<\/h2>\n<p>The principal objective of the Panic Disorder Severity Scale \u2013 Self-Report (PDSS-SR) is to deliver an empirical, psychometrically sound, standardized, and cost-effective instrument capable of quantifying the multidimensional severity profile of panic disorder. Although structured diagnostic interviews such as the Structured Clinical Interview for DSM Disorders (SCID) establish categorical diagnostic status, they fail to provide the granular, dimensional sensitivity needed to monitor symptom trajectories over time, measure subtle clinical responses to pharmacological or psychotherapeutic interventions, or quantify functional disability.<\/p>\n<p>The original clinician-administered PDSS addressed this clinical need but imposed significant operational limitations: it required substantial clinical training, formal inter-rater reliability calibration, and 15 to 25 minutes of clinical interview time per patient. In large-scale randomized controlled trials (RCTs), health services research, and high-volume ambulatory behavioral health clinics, the logistical demands of clinician-administered evaluations can prove prohibitive. The PDSS-SR was designed to eliminate interviewer burden while retaining the descriptive anchors, dimensional breadth, and clinical validity of the clinician scale.<\/p>\n<p>The instrument is engineered for several primary applications:<\/p>\n<ul>\n<li><strong>Primary Outcome Measurement in Clinical Trials:<\/strong> Serving as a gold-standard endpoint to evaluate the comparative efficacy of pharmacological regimens (e.g., selective serotonin reuptake inhibitors [SSRIs], serotonin-norepinephrine reuptake inhibitors [SNRIs], benzodiazepines) and specialized psychotherapies (e.g., cognitive-behavioral therapy, panic-focused psychodynamic psychotherapy).<\/li>\n<li><strong>Measurement-Based Care (MBC):<\/strong> Facilitating session-by-session tracking in outpatient psychiatric and psychological settings to rapidly identify non-responders, treatment plateaus, or symptom exacerbations.<\/li>\n<li><strong>Epidemiological and Registry Screening:<\/strong> Providing a validated dimensional severity marker across community, university, and medical center health registries without necessitating specialized psychiatric personnel.<\/li>\n<li><strong>Assessment of Residual Symptoms and Relapse Vulnerability:<\/strong> Clarifying whether patients who have achieved full remission of acute panic attacks continue to suffer from debilitating anticipatory anxiety, interoceptive phobic avoidance, or social-occupational dysfunction.<\/li>\n<\/ul>\n<h2>Psychological Construct<\/h2>\n<p>The PDSS-SR operationalizes panic disorder not as a monolithic categorical diagnosis, but as a complex clinical syndrome comprised of interconnected physiological, cognitive, behavioral, and functional dimensions. Rather than merely tabulating the presence or absence of autonomic symptoms, the instrument isolates seven mutually non-redundant facets of panic pathology:<\/p>\n<h3>1. Panic Attack and Limited-Symptom Episode Frequency<\/h3>\n<p>Item 1 captures the episodic burst of autonomic distress. The construct distinguishes between full panic attacks (characterized by four or more crescendo autonomic\/cognitive symptoms such as palpitations, dyspnea, trembling, dizziness, derealization, or fears of dying\/losing control) and limited-symptom attacks (episodes involving fewer than four somatic symptoms). By evaluating the total incidence over a 7-day retrospective window, this dimension reflects acute episodic arousal.<\/p>\n<h3>2. Distress During Panic Episodes<\/h3>\n<p>Item 2 quantifies the subjective affective and physiological distress experienced while an attack is occurring. Individuals exhibit substantial variance in distress: one patient may experience frequent attacks that are managed with minimal terror, whereas another may experience infrequent attacks marked by catastrophic subjective torment, agonizing physical pain, and profound terror. Disentangling frequency from distress prevents mischaracterizing patients who experience few, yet intensely traumatic, episodes.<\/p>\n<h3>3. Anticipatory Anxiety and Catastrophic Cognitions<\/h3>\n<p>Item 3 evaluates the chronic, inter-paroxysmal apprehension regarding future panic episodes. Often described as &#8220;fear of fear,&#8221; this construct encompasses persistent worry about the timing of future attacks, fears of immediate catastrophic somatic consequences (e.g., heart attacks, strokes), and concerns over catastrophic psychological breakdown (e.g., &#8220;going crazy&#8221; or losing complete behavioral control).<\/p>\n<h3>4. Agoraphobic (Situational\/Exteroceptive) Avoidance<\/h3>\n<p>Item 4 measures avoidance or enduring with severe distress external locations and situations from which escape might be difficult or embarrassing, or in which immediate medical assistance would be unavailable in the event of panic symptoms. Target contexts include public transit, enclosed spaces (cinemas, tunnels), open spaces, highway driving, and being alone outside or at home.<\/p>\n<h3>5. Interoceptive Phobic Avoidance<\/h3>\n<p>Item 5 assesses a uniquely sensitive hallmark of panic disorder: the phobic avoidance of benign, internally generated somatic sensations that resemble panic-related autonomic surges. This construct reflects conditioned fear of elevated heart rate, perspiration, peripheral temperature changes, or lightheadedness, leading patients to avoid physical exercise, caffeine, sexual intercourse, sudden ambient temperature changes, emotional excitement, or stimulating media.<\/p>\n<h3>6. Work and Occupational Impairment<\/h3>\n<p>Item 6 assesses the functional disruption caused across occupational, educational, and domestic responsibilities. It tracks absenteeism, presenteeism (diminished productivity while at work), inability to perform homemaking duties, academic failure, or complete career derailment attributable to panic symptoms and avoidance.<\/p>\n<h3>7. Social and Interpersonal Impairment<\/h3>\n<p>Item 7 measures the erosion of social engagement, familial interactions, recreation, and interpersonal connections. It captures withdrawal from social gatherings, strain on romantic partnerships, forced dependence upon a designated &#8220;safety person&#8221; for community navigation, and the restriction of leisure activities.<\/p>\n<h2>Theoretical Framework<\/h2>\n<p>The construction of the PDSS-SR is grounded in the convergence of experimental psychopathology, cognitive behavioral theory, and contemporary neurobiological models of fear circuitry.<\/p>\n<h3>Cognitive Model of Panic Disorder<\/h3>\n<p>The scale heavily operationalizes <a href=\"https:\/\/en.wikipedia.org\/wiki\/Aaron_Beck\" target=\"_blank\" rel=\"noopener noreferrer\">Aaron Beck<\/a> and <a href=\"https:\/\/en.wikipedia.org\/wiki\/David_M._Clark\" target=\"_blank\" rel=\"noopener noreferrer\">David M. Clark&#8217;s<\/a> (1986) cognitive model of panic. Clark posited that panic attacks occur when individuals possess enduring cognitive schemas that cause them to misinterpret benign bodily sensations (e.g., normal cardiovascular fluctuations, transient respiratory sensations) as immediate indicators of impending catastrophic disasters, such as myocardial infarction, cerebrovascular accident, asphyxiation, or psychosis. This misinterpretation triggers an acute fear response, releasing autonomic adrenaline surges, which intensify somatic cues, fueling a vicious, escalating crescendo cycle. The PDSS-SR captures this dynamic across its items: sensations escalate into full panic attacks (Item 1), distress is magnified by catastrophic cognitions (Item 2), anticipatory anxiety maintains vigilance for bodily sensations (Item 3), and avoidance behaviors emerge to avert the perceived threat (Items 4 and 5).<\/p>\n<h3>Barlow\u2019s Triple Vulnerability Theory<\/h3>\n<p>The structural scope of the PDSS aligns with <a href=\"https:\/\/en.wikipedia.org\/wiki\/David_H._Barlow\" target=\"_blank\" rel=\"noopener noreferrer\">David H. Barlow&#8217;s<\/a> (1988, 2002) Triple Vulnerability Model of emotional disorders, which postulates three etiologic components:<\/p>\n<ol>\n<li><em>Generalized Biological Vulnerability:<\/em> A neurobiological diathesis toward hyper-reactive autonomic arousal and behavioral inhibition.<\/li>\n<li><em>Generalized Psychological Vulnerability:<\/em> A deep-seated sense that life events, bodily states, and affective surges are unpredictable and uncontrollable.<\/li>\n<li><em>Specific Psychological Vulnerability:<\/em> Conditioned learning specifically oriented around somatic and autonomic cues, whereby autonomic sensations are perceived as inherently hazardous.<\/li>\n<\/ol>\n<p>The PDSS-SR evaluates the manifestation of these vulnerabilities: false alarms trigger full attacks (Item 1), learned alarms foster interoceptive phobic avoidance (Item 5), and anxious apprehension fosters chronic anticipatory worry (Item 3), which culminates in situational constriction (Item 4) and extensive functional disability (Items 6 and 7).<\/p>\n<h3>Classical Conditioning and Interoceptive Avoidance<\/h3>\n<p>From an interoceptive conditioning perspective (Razran, 1961; Bouton et al., 2001), low-level internal physiological sensations (conditioned stimuli, or CS) become paired with the terrifying unconditioned emotional reaction of the initial panic attack (unconditioned stimulus\/response, UCS\/UCR). Consequently, elevated heart rate, rapid breathing, or vestibular changes reliably trigger defensive physiological activation. To forestall these symptoms, patients engage in safety-seeking behaviors and interoceptive avoidance (Item 5), which are maintained through negative reinforcement, ultimately driving widespread socio-occupational impairment.<\/p>\n<h2>Validity<\/h2>\n<p>Extensive psychometric investigations have established the construct, criterion, convergent, discriminant, and treatment-sensitive validity of the PDSS-SR.<\/p>\n<h3>Convergent and Criterion Validity<\/h3>\n<p>In the index validation study by Houck et al. (2002), the PDSS-SR demonstrated strong concordance with the clinician-administered PDSS total score (<span class=\"arabpsy-math-inline\" data-latex=\"r = .81\">$r = .81$<\/span>), indicating that patient-reported self-ratings reliably capture clinical severity as assessed by trained interviewers. Furthermore, the correlation between PDSS-SR and the Hamilton Anxiety Rating Scale (HAM-A) ranged from <span class=\"arabpsy-math-inline\" data-latex=\".50\">$.50$<\/span> to <span class=\"arabpsy-math-inline\" data-latex=\".68\">$.68$<\/span>, while correlations with the Beck Anxiety Inventory (BAI) ranged from <span class=\"arabpsy-math-inline\" data-latex=\".60\">$.60$<\/span> to <span class=\"arabpsy-math-inline\" data-latex=\".74\">$.74$<\/span>. In examining agoraphobic avoidance specifically, the PDSS-SR Item 4 correlated highly (<span class=\"arabpsy-math-inline\" data-latex=\"r = .65\u2013.78\">$r = .65\u2013.78$<\/span>) with the Mobility Inventory for Agoraphobia (MIA) Avoidance Alone Subscale.<\/p>\n<h3>Discriminant Validity<\/h3>\n<p>Discriminant validity was established by comparing the PDSS-SR with instruments measuring disparate psychopathological constructs. Correlations with depressive symptom inventories (e.g., the Beck Depression Inventory [BDI] and the Montgomery-\u00c5sberg Depression Rating Scale [MADRS]) typically fall within the moderate range (<span class=\"arabpsy-math-inline\" data-latex=\"r = .35\u2013.48\">$r = .35\u2013.48$<\/span>). While comorbid depressive symptoms are common in chronic panic disorder, the PDSS-SR accounts for unique variance specific to autonomic surges, phobic avoidance, and interoceptive distress.<\/p>\n<h3>Sensitivity to Treatment Change and Cut-Off Benchmarks<\/h3>\n<p>The PDSS-SR is sensitive to clinical changes during psychotherapeutic (CBT) and pharmacotherapeutic trials, showing effect sizes (Cohen&#8217;s <span class=\"arabpsy-math-inline\" data-latex=\"d\">$d$<\/span>) exceeding $1.20$ from pre-to post-treatment in active treatment arms. Receiver Operating Characteristic (<a href=\"https:\/\/en.wikipedia.org\/wiki\/Receiver_operating_characteristic\" target=\"_blank\" rel=\"noopener noreferrer\">ROC<\/a>) analyses demonstrate excellent classification accuracy (Area Under the Curve, <span class=\"arabpsy-math-inline\" data-latex=\"\\text{AUC} ge .90\">$\\text{AUC} ge .90$<\/span>):<\/p>\n<ul>\n<li><strong>Clinical Threshold:<\/strong> A composite score of <span class=\"arabpsy-math-inline\" data-latex=\"ge 8\">$ge 8$<\/span> or $9$ optimally differentiates individuals with active, clinically significant panic disorder from normal or subclinical cohorts (sensitivity <span class=\"arabpsy-math-inline\" data-latex=\"\\approx 88%\">$\\approx 88%$<\/span>, specificity <span class=\"arabpsy-math-inline\" data-latex=\"\\approx 84%\">$\\approx 84%$<\/span>).<\/li>\n<li><strong>Remission \/ Normalcy Benchmark:<\/strong> Post-treatment composite scores of <span class=\"arabpsy-math-inline\" data-latex=\"le 3\">$le 3$<\/span> (or an average item score <span class=\"arabpsy-math-inline\" data-latex=\"le 0.43\">$le 0.43$<\/span>) correspond with clinical remission criteria on the Clinical Global Impressions &#8211; Improvement scale (CGI-I) of &#8220;very much improved&#8221; or &#8220;normal, not at all ill.&#8221;<\/li>\n<li><strong>Subclinical \/ Mild Severity:<\/strong> Scores of <span class=\"arabpsy-math-inline\" data-latex=\"4\u20137\">$4\u20137$<\/span>.<\/li>\n<li><strong>Moderate Severity:<\/strong> Scores of <span class=\"arabpsy-math-inline\" data-latex=\"8\u201310\">$8\u201310$<\/span>.<\/li>\n<li><strong>Marked \/ Severe Impairment:<\/strong> Scores of <span class=\"arabpsy-math-inline\" data-latex=\"11\u201315\">$11\u201315$<\/span>.<\/li>\n<li><strong>Extreme Severity:<\/strong> Scores <span class=\"arabpsy-math-inline\" data-latex=\"ge 16\">$ge 16$<\/span>.<\/li>\n<\/ul>\n<h2>Reliability<\/h2>\n<p>The PDSS-SR exhibits high internal consistency, reproducibility, and temporal stability across diverse clinical environments.<\/p>\n<h3>Internal Consistency<\/h3>\n<p>In the original validation study by Houck et al. (2002), the internal consistency of the PDSS-SR was excellent, with a Cronbach&#8217;s alpha of <span class=\"arabpsy-math-inline\" data-latex=\"\\alpha = .91\">$\\alpha = .91$<\/span> to <span class=\"arabpsy-math-inline\" data-latex=\".94\">$.94$<\/span> in an outpatient cohort with panic disorder (<span class=\"arabpsy-math-inline\" data-latex=\"N = 186\">$N = 186$<\/span>). Subsequent multi-center replications and international adaptation trials have reported consistent findings:<\/p>\n<ul>\n<li>American validation cohorts: <span class=\"arabpsy-math-inline\" data-latex=\"\\alpha = .92\">$\\alpha = .92$<\/span> (Houck et al., 2002; Shear et al., 2001).<\/li>\n<li>Spanish version: <span class=\"arabpsy-math-inline\" data-latex=\"\\alpha = .89\">$\\alpha = .89$<\/span> (Bobes et al., 2004).<\/li>\n<li>Turkish version: <span class=\"arabpsy-math-inline\" data-latex=\"\\alpha = .91\">$\\alpha = .91$<\/span> (Monkul et al., 2004).<\/li>\n<li>Japanese version: <span class=\"arabpsy-math-inline\" data-latex=\"\\alpha = .88\">$\\alpha = .88$<\/span> (Yamamoto et al., 2004).<\/li>\n<li>German translation: <span class=\"arabpsy-math-inline\" data-latex=\"\\alpha = .90\">$\\alpha = .90$<\/span> (Rief et al., 2004).<\/li>\n<\/ul>\n<p>Item-total correlation coefficients range from <span class=\"arabpsy-math-inline\" data-latex=\".58\">$.58$<\/span> to <span class=\"arabpsy-math-inline\" data-latex=\".82\">$.82$<\/span>, confirming that every item contributes meaningfully to the overall severity construct without psychometric redundancy.<\/p>\n<h3>Test-Retest Stability<\/h3>\n<p>In clinically stable patients evaluated over a 1- to 2-week baseline period prior to intervention, the intraclass correlation coefficient (ICC) and Pearson test-retest correlation coefficients ranged from <span class=\"arabpsy-math-inline\" data-latex=\"r = .71\">$r = .71$<\/span> to <span class=\"arabpsy-math-inline\" data-latex=\"r = .88\">$r = .88$<\/span>. This demonstrates strong temporal stability when clinical state is unchanging, alongside sensitivity to therapeutic change once active treatment commences.<\/p>\n<h2>Factor Analysis<\/h2>\n<p>The structural dimensionality of the PDSS-SR has been thoroughly evaluated using both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA).<\/p>\n<h3>Unidimensional Architecture vs. Correlated Two-Factor Model<\/h3>\n<p>Early psychometric evaluations postulated a single general severity factor accounting for the majority of the variance (eigenvalue <span class=\"arabpsy-math-inline\" data-latex=\"&gt; 4.0\">$> 4.0$<\/span>, accounting for over <span class=\"arabpsy-math-inline\" data-latex=\"55%\">$55%$<\/span> of total variance). However, rigorous CFA studies (e.g., Brown et al., 2001; Shear et al., 2001; Yamamoto et al., 2004) frequently report that a <strong>correlated two-factor model<\/strong> yields superior goodness-of-fit indices:<\/p>\n<ul>\n<li><strong>Factor 1: Core Panic &amp; Interoceptive Symptoms:<\/strong> Comprising Item 1 (Attack Frequency), Item 2 (Panic Distress), Item 3 (Anticipatory Anxiety), and Item 5 (Interoceptive Avoidance). Standardized factor loadings (<span class=\"arabpsy-math-inline\" data-latex=\"\u03bb\">$\u03bb$<\/span>) typically range between <span class=\"arabpsy-math-inline\" data-latex=\".68\">$.68$<\/span> and <span class=\"arabpsy-math-inline\" data-latex=\".86\">$.86$<\/span>.<\/li>\n<li><strong>Factor 2: Agoraphobic Avoidance &amp; Functional Impairment:<\/strong> Comprising Item 4 (Agoraphobic Avoidance), Item 6 (Work\/Role Impairment), and Item 7 (Social Impairment). Standardized factor loadings (<span class=\"arabpsy-math-inline\" data-latex=\"\u03bb\">$\u03bb$<\/span>) typically range between <span class=\"arabpsy-math-inline\" data-latex=\".72\">$.72$<\/span> and <span class=\"arabpsy-math-inline\" data-latex=\".89\">$.89$<\/span>.<\/li>\n<\/ul>\n<h3>Confirmatory Factor Analysis Fit Indices<\/h3>\n<p>Across validation cohorts, the correlated two-factor model consistently meets modern structural equation modeling thresholds:<\/p>\n<ul>\n<li>Comparative Fit Index (<strong>CFI<\/strong>) <span class=\"arabpsy-math-inline\" data-latex=\"ge .97\">$ge .97$<\/span><\/li>\n<li>Tucker-Lewis Index (<strong>TLI<\/strong>) <span class=\"arabpsy-math-inline\" data-latex=\"ge .96\">$ge .96$<\/span><\/li>\n<li>Root Mean Square Error of Approximation (<strong>RMSEA<\/strong>) <span class=\"arabpsy-math-inline\" data-latex=\"le .054\">$le .054$<\/span> (90% CI [.031, .078])<\/li>\n<li>Standardized Root Mean Square Residual (<strong>SRMR<\/strong>) <span class=\"arabpsy-math-inline\" data-latex=\"le .036\">$le .036$<\/span><\/li>\n<\/ul>\n<p>The latent inter-factor correlation between Factor 1 and Factor 2 is substantial (<span class=\"arabpsy-math-inline\" data-latex=\"r \\approx .65\u2013.78\">$r \\approx .65\u2013.78$<\/span>), justifying the clinical practice of summing all seven items into a single composite score while maintaining the theoretical distinction between acute somatic panic anxiety and downstream behavioral\/functional consequences.<\/p>\n<h2>Instrument \/ Measurement Tool<\/h2>\n<ul>\n<li><strong>Instrument Name:<\/strong> Panic Disorder Severity Scale \u2013 Self-Report (PDSS-SR)<\/li>\n<li><strong>Instrument Type:<\/strong> Self-administered dimensional psychometric rating scale<\/li>\n<li><strong>Respondent Target:<\/strong> Adolescents and adults (ages 16\u201375) evaluated for or diagnosed with Panic Disorder (with or without Agoraphobia)<\/li>\n<li><strong>Item Count:<\/strong> 7 discrete items<\/li>\n<li><strong>Assessment Window:<\/strong> Past 7 days (the past week)<\/li>\n<li><span class=\"arabpsy-eq\" dir=\"ltr\"><strong>Response Format:<\/strong> 5-point ordinal scale (0 to 4), with specific descriptive anchors for each item (e.g., 0 = None, 1 = Mild, 2 = Moderate, 3 = Severe, 4 = Extreme)<\/span><\/li>\n<li><strong>Scoring Modality:<\/strong>\n<ul>\n<li><em>Total Composite Score:<\/em> Calculated by summing the numerical ratings across all 7 items (range: 0 to 28).<\/li>\n<li><em>Average Item Score:<\/em> Calculated by dividing the composite total score by 7 (range: 0.0 to 4.0).<\/li>\n<li><em>Directionality:<\/em> Directly linear; higher scores correspond to more severe panic pathology, avoidance, and functional disability.<\/li>\n<li><em>Missing Data Rule:<\/em> If 1 item is missing, the mean of the remaining 6 items can be imputed; if <span class=\"arabpsy-math-inline\" data-latex=\"ge 2\">$ge 2$<\/span> items are missing, the overall score is invalidated.<\/li>\n<\/ul>\n<\/li>\n<li><strong>Administration Time:<\/strong> Approximately 5 to 10 minutes<\/li>\n<li><strong>Clinical Interpretive Cutoffs:<\/strong>\n<ul>\n<li><strong>0 \u2013 3:<\/strong> Remission \/ Non-clinical Range<\/li>\n<li><strong>4 \u2013 7:<\/strong> Mild \/ Borderline Panic Disorder Severity<\/li>\n<li><strong>8 \u2013 10:<\/strong> Moderate Panic Disorder Severity (Common entry threshold for clinical trials)<\/li>\n<li><strong>11 \u2013 15:<\/strong> Marked \/ Severe Panic Disorder<\/li>\n<li><strong>16 \u2013 28:<\/strong> Extreme \/ Incapacitating Panic Disorder Severity<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h2>Permissions &#038; Fee and Test Year<\/h2>\n<ul>\n<li><strong>Year of Publication:<\/strong> The clinician interview (PDSS) was published in 1997; the self-report version (PDSS-SR) was published in 2002.<\/li>\n<li><strong>Copyright &amp; Permissions:<\/strong> The PDSS and PDSS-SR are copyrighted by M. Katherine Shear, M.D., and colleagues. However, the instrument is widely placed in the public domain for academic, clinical, and non-commercial research purposes without charging licensing fees.<\/li>\n<li><strong>Commercial &amp; Electronic Use:<\/strong> For inclusion in commercial platforms, proprietary electronic medical record systems, or pharmaceutical clinical trials, permission and licensing agreements should be directed through the authors, the copyright holders, or the Department of Psychiatry at Columbia University \/ University of Pittsburgh.<\/li>\n<\/ul>\n<h2>References<\/h2>\n<ul>\n<li>Barlow, D. H. (1988). <em>Anxiety and its disorders: The nature and treatment of anxiety and panic<\/em>. Guilford Press.<\/li>\n<li>Barlow, D. H. (2002). <em>Anxiety and its disorders: The nature and treatment of anxiety and panic<\/em> (2nd ed.). Guilford Press.<\/li>\n<li>Bobes, J., Bad\u00eda, X., Luque, A., Garc\u00eda, M., Gonz\u00e1lez, M. P., &amp; Dal-R\u00e9, R. (2004). Validaci\u00f3n de las versiones en espa\u00f1ol de los cuestionarios PDSS (Panic Disorder Severity Scale) y PDSS-SR (Panic Disorder Severity Scale Self-Report) para el trastorno de angustia. <em>Medicina Cl\u00ednica<\/em>, 122(5), 161\u2013168. <a href=\"https:\/\/doi.org\/10.1016\/S0025-7753(04)74175-9\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/doi.org\/10.1016\/S0025-7753(04)74175-9<\/a><\/li>\n<li>Bouton, M. E., Mineka, S., &amp; Barlow, D. H. (2001). A modern learning theory perspective on the etiology of panic disorder. <em>Psychological Review<\/em>, 108(1), 4\u201332. <a href=\"https:\/\/doi.org\/10.1037\/0033-295X.108.1.4\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/doi.org\/10.1037\/0033-295X.108.1.4<\/a><\/li>\n<li>Brown, T. A., White, K. S., &amp; Barlow, D. H. (2005). A psychometric reanalysis of the Panic Disorder Severity Scale. <em>Behaviour Research and Therapy<\/em>, 43(11), 1399\u20131409. <a href=\"https:\/\/doi.org\/10.1016\/j.brat.2004.10.005\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/doi.org\/10.1016\/j.brat.2004.10.005<\/a><\/li>\n<li>Clark, D. M. (1986). A cognitive approach to panic. <em>Behaviour Research and Therapy<\/em>, 24(4), 461\u2013470. <a href=\"https:\/\/doi.org\/10.1016\/0005-7967(86)90011-2\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/doi.org\/10.1016\/0005-7967(86)90011-2<\/a><\/li>\n<li>Houck, P. R., Spiegel, D. A., Shear, M. K., &amp; Rucci, P. (2002). Reliability of the self-report version of the Panic Disorder Severity Scale. <em>Depression and Anxiety<\/em>, 15(4), 183\u2013185. <a href=\"https:\/\/doi.org\/10.1002\/da.10049\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/doi.org\/10.1002\/da.10049<\/a><\/li>\n<li>Monkul, E. S., Tural, \u00dc., Onur, E., Fidaner, H., Alkin, T., &amp; Shear, M. K. (2004). Panic Disorder Severity Scale: Reliability and validity of the Turkish version. <em>Depression and Anxiety<\/em>, 20(1), 8\u201316. <a href=\"https:\/\/doi.org\/10.1002\/da.20011\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/doi.org\/10.1002\/da.20011<\/a><\/li>\n<li>Rief, W., Trenkamp, S., Auer, C., &amp; Fichter, M. M. (2004). Die Messung der Panikst\u00f6rungsschwere mit der Panic Disorder Severity Scale (PDSS). <em>Verhaltenstherapie<\/em>, 14(1), 32\u201339. <a href=\"https:\/\/doi.org\/10.1159\/000077864\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/doi.org\/10.1159\/000077864<\/a><\/li>\n<li>Shear, M. K., Brown, T. A., Barlow, D. H., Money, R., Sholomskas, D. E., Woods, S. W., Gorman, J. M., &amp; Papp, L. A. (1997). Multicenter collaborative panic disorder severity scale. <em>American Journal of Psychiatry<\/em>, 154(11), 1571\u20131575. <a href=\"https:\/\/doi.org\/10.1176\/ajp.154.11.1571\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/doi.org\/10.1176\/ajp.154.11.1571<\/a><\/li>\n<li>Shear, M. K., Rucci, P., Williams, J., Frank, E., Grochocinski, V., Vander Bilt, J., Houck, P., &amp; Wang, T. (2001). Reliability and validity of the Panic Disorder Severity Scale: A replication study. <em>Depression and Anxiety<\/em>, 13(4), 157\u2013165. <a href=\"https:\/\/doi.org\/10.1002\/da.1032\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/doi.org\/10.1002\/da.1032<\/a><\/li>\n<li>Yamamoto, I., Zhang, J., Sasaki, T., Inubushi, M., &amp; Furukawa, T. A. (2004). The Japanese version of the Panic Disorder Severity Scale: Psychometric properties and its factor structure. <em>Journal of Affective Disorders<\/em>, 82(2), 277\u2013281. <a href=\"https:\/\/doi.org\/10.1016\/j.jad.2003.11.004\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/doi.org\/10.1016\/j.jad.2003.11.004<\/a><\/li>\n<\/ul>\n<h2>13. Items of the Scale (Questionnaire)<\/h2>\n<div class=\"wpt-scale-items-container\" style=\"background:#ffffff; border:1px solid #e2e8f0; border-radius:12px; margin:28px 0; overflow:hidden; box-shadow:0 4px 12px rgba(0,0,0,0.03);\">\n<div class=\"wpt-scale-notice\" style=\"direction:ltr; text-align:left; background:#f8fafc; border-bottom:1px solid #e2e8f0; padding:14px 20px; font-size:13.5px; color:#475569; font-weight:500;\">\n    Below are the authentic scale items in their original language as published in the standard psychometric validation studies, without modification or translation to preserve instrument validity and reliability:\n  <\/div>\n<div class=\"wpt-scale-english-box\" style=\"direction:ltr; text-align:left; padding:20px 24px; font-family:-apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Helvetica, Arial, sans-serif; font-size:14.5px; color:#1e293b; line-height:1.7;\">\n<div class=\"wpt-scale-instructions\" style=\"background:#f1f5f9; border-left:4px solid #64748b; border-radius:0 8px 8px 0; padding:12px 16px; margin-bottom:16px; font-size:13.5px; color:#334155;\">\n      <strong style=\"color:#0f172a;\">Instructions \/ Directions:<\/strong> Several of the following questions refer to panic attacks and limited symptom episodes. For this questionnaire, we define a panic attack as a sudden rush of fear or anxiety accompanied by at least 4 of the symptoms listed below. A limited symptom episode is like a panic attack but involves fewer than 4 symptoms. Symptoms include: rapid heart rate, sweating, trembling, shortness of breath, feeling of choking, chest pain\/discomfort, nausea\/stomach distress, dizziness\/unsteadiness, feelings of unreality or detachment, fear of losing control or going crazy, fear of dying, numbness\/tingling, chills or hot flushes. Please answer the following questions based on the past week.\n    <\/div>\n<div class=\"wpt-scale-response-format\" style=\"background:#eff6ff; border-left:4px solid #3b82f6; border-radius:0 8px 8px 0; padding:12px 16px; margin-bottom:14px; font-size:13.5px; color:#1e40af;\">\n      <span class=\"arabpsy-eq\" dir=\"ltr\"><strong style=\"color:#1e3a8a;\">Response Scale:<\/strong> 5-point scale (0 to 4), with specific descriptive anchors for each item (e.g., 0 = None, 1 = Mild, 2 = Moderate, 3 = Severe, 4 = Extreme)<\/span>\n    <\/div>\n<div class=\"wpt-scale-reverse-scoring\" style=\"background:#fffbeb; border-left:4px solid #f59e0b; border-radius:0 8px 8px 0; padding:12px 16px; margin-bottom:14px; font-size:13.5px; color:#92400e;\">\n      <strong style=\"color:#78350f;\">Scoring \/ Reverse Items:<\/strong> Items are rated from 0 to 4 and summed to yield a total score ranging from 0 to 28. Alternatively, an average item score (total score divided by 7) can be computed ranging from 0 to 4. Higher scores indicate greater panic disorder severity.\n    <\/div>\n<div class=\"wpt-scale-item-row\" style=\"background:#ffffff; border:1px solid #e2e8f0; border-radius:8px; padding:12px 16px; margin-bottom:10px; display:flex; align-items:flex-start; gap:12px; box-shadow:0 1px 2px rgba(0,0,0,0.02);\">\n  <span style=\"display:inline-flex; align-items:center; justify-content:center; min-width:28px; height:28px; background:#2563eb; color:#ffffff; font-weight:700; font-size:12.5px; border-radius:50%; flex-shrink:0; margin-top:1px;\">1<\/span><\/p>\n<div style=\"flex:1; color:#0f172a; font-size:14.5px; font-weight:500; line-height:1.6;\">How many panic and limited symptom attacks did you have during the week?<\/div>\n<\/div>\n<div class=\"wpt-scale-item-row\" style=\"background:#ffffff; border:1px solid #e2e8f0; border-radius:8px; padding:12px 16px; margin-bottom:10px; display:flex; align-items:flex-start; gap:12px; box-shadow:0 1px 2px rgba(0,0,0,0.02);\">\n  <span style=\"display:inline-flex; align-items:center; justify-content:center; min-width:28px; height:28px; background:#2563eb; color:#ffffff; font-weight:700; font-size:12.5px; border-radius:50%; flex-shrink:0; margin-top:1px;\">2<\/span><\/p>\n<div style=\"flex:1; color:#0f172a; font-size:14.5px; font-weight:500; line-height:1.6;\">If you had any panic attacks during the past week, how distressing (uncomfortable, frightening) were they while they were happening?<\/div>\n<\/div>\n<div class=\"wpt-scale-item-row\" style=\"background:#ffffff; border:1px solid #e2e8f0; border-radius:8px; padding:12px 16px; margin-bottom:10px; display:flex; align-items:flex-start; gap:12px; box-shadow:0 1px 2px rgba(0,0,0,0.02);\">\n  <span style=\"display:inline-flex; align-items:center; justify-content:center; min-width:28px; height:28px; background:#2563eb; color:#ffffff; font-weight:700; font-size:12.5px; border-radius:50%; flex-shrink:0; margin-top:1px;\">3<\/span><\/p>\n<div style=\"flex:1; color:#0f172a; font-size:14.5px; font-weight:500; line-height:1.6;\">During the past week, how much have you worried or felt anxious about when your next panic attack would occur or about fears related to the attacks (for example, that they could mean you have physical or mental illness or could lose control)?<\/div>\n<\/div>\n<div class=\"wpt-scale-item-row\" style=\"background:#ffffff; border:1px solid #e2e8f0; border-radius:8px; padding:12px 16px; margin-bottom:10px; display:flex; align-items:flex-start; gap:12px; box-shadow:0 1px 2px rgba(0,0,0,0.02);\">\n  <span style=\"display:inline-flex; align-items:center; justify-content:center; min-width:28px; height:28px; background:#2563eb; color:#ffffff; font-weight:700; font-size:12.5px; border-radius:50%; flex-shrink:0; margin-top:1px;\">4<\/span><\/p>\n<div style=\"flex:1; color:#0f172a; font-size:14.5px; font-weight:500; line-height:1.6;\">During the past week, were there any places or situations (e.g., public transportation, movie theaters, crowds, being alone, walking, driving) you avoided, or felt afraid of (tolerated with fear), because of fear of having a panic attack?<\/div>\n<\/div>\n<div class=\"wpt-scale-item-row\" style=\"background:#ffffff; border:1px solid #e2e8f0; border-radius:8px; padding:12px 16px; margin-bottom:10px; display:flex; align-items:flex-start; gap:12px; box-shadow:0 1px 2px rgba(0,0,0,0.02);\">\n  <span style=\"display:inline-flex; align-items:center; justify-content:center; min-width:28px; height:28px; background:#2563eb; color:#ffffff; font-weight:700; font-size:12.5px; border-radius:50%; flex-shrink:0; margin-top:1px;\">5<\/span><\/p>\n<div style=\"flex:1; color:#0f172a; font-size:14.5px; font-weight:500; line-height:1.6;\">During the past week, were there any activities (e.g., physical exertion, sexual relations, taking a cold shower, drinking coffee or tea, watching an exciting or scary movie) that you avoided, or felt afraid of (tolerated with fear), because they caused physical sensations like those you feel during panic attacks or that you were afraid might trigger a panic attack?<\/div>\n<\/div>\n<div class=\"wpt-scale-item-row\" style=\"background:#ffffff; border:1px solid #e2e8f0; border-radius:8px; padding:12px 16px; margin-bottom:10px; display:flex; align-items:flex-start; gap:12px; box-shadow:0 1px 2px rgba(0,0,0,0.02);\">\n  <span style=\"display:inline-flex; align-items:center; justify-content:center; min-width:28px; height:28px; background:#2563eb; color:#ffffff; font-weight:700; font-size:12.5px; border-radius:50%; flex-shrink:0; margin-top:1px;\">6<\/span><\/p>\n<div style=\"flex:1; color:#0f172a; font-size:14.5px; font-weight:500; line-height:1.6;\">During the past week, how much did the above symptoms (panic and limited symptom attacks, worry about attacks, and fear of situations and activities because of attacks) interfere with your ability to work or carry out your usual responsibilities at work, school, or home?<\/div>\n<\/div>\n<div class=\"wpt-scale-item-row\" style=\"background:#ffffff; border:1px solid #e2e8f0; border-radius:8px; padding:12px 16px; margin-bottom:10px; display:flex; align-items:flex-start; gap:12px; box-shadow:0 1px 2px rgba(0,0,0,0.02);\">\n  <span style=\"display:inline-flex; align-items:center; justify-content:center; min-width:28px; height:28px; background:#2563eb; color:#ffffff; font-weight:700; font-size:12.5px; border-radius:50%; flex-shrink:0; margin-top:1px;\">7<\/span><\/p>\n<div style=\"flex:1; color:#0f172a; font-size:14.5px; font-weight:500; line-height:1.6;\">During the past week, how much did panic and limited symptom attacks, worry about attacks and fear of situations and activities interfere with your social life (e.g., relationships with friends, family, going to parties or other social events)?<\/div>\n<\/div><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>A comprehensive psychometric guide to the Panic Disorder Severity Scale \u2013 Self-Report (PDSS-SR), detailing its theoretical framework, validity, reliability, factor structure, scoring parameters, and full authentic items.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","categories":[1132,476,66,2],"tags":[1534,1357,1372,466,1533,1532,6],"class_list":["post-346","psych_scale","type-psych_scale","status-publish","hentry","category-anxiety-disorders","category-assessment-tools","category-clinical-psychology","category-psychometrics","tag-agoraphobia","tag-anxiety-assessment","tag-clinical-trials","tag-cognitive-behavioral-therapy","tag-panic-disorder","tag-pdss-sr","tag-psychometrics"],"_links":{"self":[{"href":"https:\/\/ashadocs.org\/index.php?rest_route=\/wp\/v2\/psych_scale\/346","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ashadocs.org\/index.php?rest_route=\/wp\/v2\/psych_scale"}],"about":[{"href":"https:\/\/ashadocs.org\/index.php?rest_route=\/wp\/v2\/types\/psych_scale"}],"author":[{"embeddable":true,"href":"https:\/\/ashadocs.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ashadocs.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=346"}],"version-history":[{"count":0,"href":"https:\/\/ashadocs.org\/index.php?rest_route=\/wp\/v2\/psych_scale\/346\/revisions"}],"wp:attachment":[{"href":"https:\/\/ashadocs.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=346"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ashadocs.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=346"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ashadocs.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=346"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}